0000014272-18-000079.txt : 20180313 0000014272-18-000079.hdr.sgml : 20180313 20180313165451 ACCESSION NUMBER: 0000014272-18-000079 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20180310 FILED AS OF DATE: 20180313 DATE AS OF CHANGE: 20180313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEUNG SANDRA CENTRAL INDEX KEY: 0001199294 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 18687143 MAIL ADDRESS: STREET 1: C/O BRISTOL MYERS SQUIBB CO STREET 2: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10164 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 4 1 wf-form4_152097446347947.xml FORM 4 X0306 4 2018-03-10 0 0000014272 BRISTOL MYERS SQUIBB CO BMY 0001199294 LEUNG SANDRA BRISTOL-MYERS SQUIBB COMPANY 345 PARK AVENUE NEW YORK NY 10154 0 1 0 0 EVP, General Counsel Common Stock, $0.10 par value 2018-03-10 4 M 0 5120 0 A 432911.333 D Common Stock, $0.10 par value 2018-03-10 4 J 0 1163 0 A 434074.333 D Common Stock, $0.10 par value 2018-03-10 4 F 0 3047 67.92 D 431027.333 D Common Stock, $0.10 par value 2018-03-10 4 M 0 4494 0 A 435521.333 D Common Stock, $0.10 par value 2018-03-10 4 J 0 262 0 A 435783.333 D Common Stock, $0.10 par value 2018-03-10 4 F 0 2307 67.92 D 433476.333 D Common Stock, $0.10 par value 2018-03-10 4 M 0 4434 0 A 437910.333 D Common Stock, $0.10 par value 2018-03-10 4 J 0 189 0 A 438099.333 D Common Stock, $0.10 par value 2018-03-10 4 F 0 2242 67.92 D 435857.333 D Common Stock, $0.10 par value 2018-03-10 4 M 0 5165 0 A 441022.333 D Common Stock, $0.10 par value 2018-03-10 4 J 0 926 0 A 441948.333 D Common Stock, $0.10 par value 2018-03-10 4 F 0 2954 67.92 D 438994.333 D Common Stock, $0.10 par value 2018-03-10 4 M 0 49683 0 A 488677.333 D Common Stock, $0.10 par value 2018-03-10 4 F 0 24092 67.92 D 464585.333 D Common Stock, $0.10 par value 6014.1047 I By BMY Savings and Investment Program Market Share Units 2018-03-10 4 M 0 5120 0 D 2018-03-10 Common Stock, $0.10 par value 5120.0 0 D Market Share Units 2018-03-10 4 M 0 4494 0 D 2019-03-10 Common Stock, $0.10 par value 4494.0 4495 D Market Share Units 2018-03-10 4 M 0 4434 0 D 2020-03-10 Common Stock, $0.10 par value 4434.0 8868 D Market Share Units 2018-03-10 4 M 0 5165 0 D 2021-03-10 Common Stock, $0.10 par value 5165.0 15498 D Market Share Units 2018-03-10 4 A 0 18942 0 A 2022-03-10 Common Stock, $0.10 par value 18942.0 18942 D Performance Shares 2018-03-10 4 M 0 49683 0 D 2018-03-10 Common Stock, $0.10 par value 49683.0 0 D Performance Shares 2018-03-10 4 A 0 28413 0 A 2021-03-10 Common Stock, $0.10 par value 28413.0 28413 D Represents vesting of one-quarter of market share units granted on March 10, 2014. Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Shares withheld for payment of taxes upon vesting of awards. Represents vesting of one-quarter of market share units granted on March 10, 2015. Represents vesting of one-quarter of market share units granted on March 10, 2016. Represents vesting of one-quarter of market share units granted on March 10, 2017. Amount represents distribution of performance shares earned under the 2015-2017 Long-Term Performance Award based on the performance factor applied in accordance with the terms of the Award and certification of performance results by the Board. Based on a plan statement as of the end of the most recent fiscal quarter Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date. Each performance share converts into one share of common stock upon distribution in the first quarter of 2018, subject to a Total Shareholder Return modifier. Each performance share converts into one share of common stock upon distribution in the first quarter of 2021. EXHIBIT LIST: EX-24 Exhibit 24 - Sandra Leung Power of Attorney /s/ Lisa A. Atkins, attorney-in-fact for Sandra Leung 2018-03-13 EX-24 2 ex-24.htm EXHIBIT 24 - SANDRA LEUNG POWER OF ATTORNEY

POWER OF ATTORNEY




    I, Sandra Leung, Executive Vice President and General Counsel of Bristol-Myers Squibb
Company (the "Company"), a corporation duly organized and existing under the laws of the
State of Delaware, in the United States of America, and having its principal place of business at
345 Park Avenue, New York, New York, do hereby constitute and appoint each of Katherine R.
Kelly, Yun Jung Choi and Lisa A. Atkins, individually, as my lawful attorney-in-fact and in my
name, place and stead to execute and deliver any and all documents relating to insider reporting
requirements under Section 16 of the Securities Exchange Act of 1934 with respect to securities
issued by the Company, including, without limitation, the execution and filing of all Forms 3, 4
and 5, and to take such other action, as such attorney considers necessary or appropriate, to
effectuate such transactions.  This Power of Attorney shall remain in full force and effect until I
am no longer required to file Forms 3, 4, and 5 with respect to securities issued by the Company,
unless earlier revoked.

    IN WITNESS WHEREOF, I have executed this Power of Attorney on this 18th day of
January, 2018.



    /s/ Sandra Leung
                              Sandra Leung